Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Monte Rosa Therapeutics to Participate in Upcoming Investor Conferences
Monte Rosa Therapeutics, Inc.'s (NASDAQ:GLUE) institutional investors lost 12% last week but have benefitted from longer-term gains [Yahoo! Finance]
Monte Rosa Therapeutics (NASDAQ:GLUE) was downgraded by analysts at Zacks Research from a "strong-buy" rating to a "hold" rating.
Monte Rosa Therapeutics (NASDAQ:GLUE) had its "overweight" rating reaffirmed by analysts at Piper Sandler.